Patents by Inventor Yeou-Guang Tsay

Yeou-Guang Tsay has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for verifying the primary structure of protein
    Patent number: 11635437
    Abstract: Disclosed herein is a method for verifying the primary structure of a protein through comparative analyses between ion clusters observed in mass spectra and a series of simulated ion clusters deduced from its putative chemical formula. The method comprises the steps of: preparing a protein sample for mass spectrometric analyses; collecting mass spectra of the protein sample; obtaining master ion cluster from a plurality of ion clusters in the mass spectra; producing a series of simulated ion clusters according to the chemical formula of the protein; finding the best fit for the master ion cluster among the series of simulated ion clusters; and verifying if said best-fit simulated ion cluster corresponds to the chemical formula of the protein.
    Type: Grant
    Filed: November 23, 2016
    Date of Patent: April 25, 2023
    Assignee: SUN JET BIOTECHNOLOGY INC.
    Inventors: Yeou Guang Tsay, Ya-Fen Chen
  • Method for treating cancer
    Patent number: 10927175
    Abstract: Provided is a method for treating a cancer in a subject in need thereof. The method comprises administering to the subject an anti-PD-1 agent in combination with one or more anticancer agents.
    Type: Grant
    Filed: August 2, 2018
    Date of Patent: February 23, 2021
    Assignee: SUN JET BIOTECHNOLOGY INC.
    Inventors: Hung-Chih Lai, Yeou-Guang Tsay
  • Combination therapy for EV71 infection
    Patent number: 10548915
    Abstract: The present invention is related to a combination for treating an EV71 infection, which comprises two or more compounds at each's non-effective level and provides an unexpected synergistic activity against EV71 replication, wherein the compound is selected from the group consisting of auranofin, ouabain, emetine, niclosamide, and S-(+)-fluoxetine.
    Type: Grant
    Filed: September 26, 2016
    Date of Patent: February 4, 2020
    Assignee: SUN JET BIOTECHNOLOGY INC.
    Inventors: Yeou Guang Tsay, Szu-Hao Kung
  • METHOD FOR TREATING CANCER
    Publication number: 20190048081
    Abstract: Provided is a method for treating a cancer in a subject in need thereof. The method comprises administering to the subject an anti-PD-1 agent in combination with one or more anticancer agents.
    Type: Application
    Filed: August 2, 2018
    Publication date: February 14, 2019
    Applicant: Sun Jet Biotechnology Inc.
    Inventors: Hung-Chih Lai, Yeou-Guang Tsay
  • METHOD FOR VERIFYING THE PRIMARY STRUCTURE OF PROTEIN
    Publication number: 20180356425
    Abstract: Disclosed herein is a method for verifying the primary structure of a protein through comparative analyses between ion clusters observed in mass spectra and a series of simulated ion clusters deduced from its putative chemical formula. The method comprises the steps of: preparing a protein sample for mass spectrometric analyses; collecting mass spectra of the protein sample; obtaining master ion cluster from a plurality of ion clusters in the mass spectra; producing a series of simulated ion clusters according to the chemical formula of the protein; finding the best fit for the master ion cluster among the series of simulated ion clusters; and verifying if said best-fit simulated ion cluster corresponds to the chemical formula of the protein.
    Type: Application
    Filed: November 23, 2016
    Publication date: December 13, 2018
    Applicant: Sun Jet Biotechnology Inc.
    Inventors: Yeou Guang TSAY, Ya-Fen CHEN
  • COMBINATION THERAPY FOR EV71 INFECTION
    Publication number: 20180264028
    Abstract: The present invention is related to a combination for treating an EV71 infection, which comprises two or more compounds at each's non-effective level and provides an unexpected synergistic activity against EV71 replication, wherein the compound is selected from the group consisting of auranofin, ouabain, emetine, niclosamide, and S-(+)-fluoxetine.
    Type: Application
    Filed: September 26, 2016
    Publication date: September 20, 2018
    Applicant: SUN JET BIOTECHNOLOGY INC.
    Inventors: Yeou Guang TSAY, Szu-Hao KUNG
  • BIOMARKERS FOR BREAST CANCER
    Publication number: 20150093331
    Abstract: The present invention relates to biomarkers, methods and assay kits for the identification, monitoring and treatment of breast cancer.
    Type: Application
    Filed: September 3, 2014
    Publication date: April 2, 2015
    Applicant: OncoLock Co., Ltd.
    Inventor: Yeou-Guang Tsay